OCULAR TOXICITY OF HIGH-DOSE INTRAVENOUS DESFERRIOXAMINE

The Lancet

Volumn 322, Issue 8343, 1983, Pages 181-184

  Davies, SallyC ^a   Hungerford, J L ^a   Arden, G B ^a   Marcus, R E ^a   Miller, M H ^a   Huehns, E R ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; IRON;

ADVERSE DRUG REACTION; CASE REPORT; DRUG DOSE; DRUG THERAPY; EYE TOXICITY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; NIGHT BLINDNESS; RETINOPATHY; THERAPY; VISUAL FIELD DEFECT; VISUAL SYSTEM;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; CATARACT; CHILD; CHILD, PRESCHOOL; DARK ADAPTATION; DEFEROXAMINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFUSIONS, PARENTERAL; IRON; MALE; PHOTORECEPTORS; SCOTOMA; THALASSEMIA; VISUAL ACUITY; VISUAL FIELDS;

EID: 0020577339     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(83)90170-8     Document Type: Article

References (12)

1. Lens opacities in thalassemia
2. Rapid desensitisation for desferrioxamine anaphylactic reaction
3. Reassessment of the use of desferrioxamine B in iron overload
4. Continuous subcutaneous administration of desferrioxamine in patients with iron overload
5. Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine
6. Ferrioxamine excretion in iron-loaded man
7. Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress
8. Desferrioxamine and trace metal excretion in chelation therapy in chronic iron overload
9. Copper metabolism in retinitis pigmentosa patients
10. Copper metabolism changes in pigmentary retinopathies and high myopia
11. Treatment of experimental siderosis bulbi, vitreous haemorrhage and corneal blood staining with desferrioxamine
12. Pathological lenticular changes in animals after long-term administration of elevated doses of Desferal